Yvonne Hernandez-Kapila | Infectious Diseases | Best Researcher Award

Published on by Infectious

Dr. Yvonne Hernandez-Kapila | Infectious Diseases | Best Researcher Award 

Professor | UCLA | United States

Dr. Yvonne L. Hernandez-Kapila is a distinguished clinician-scientist, academic leader, and global research contributor recognized for her transformative work in oral biology, periodontology, and cancer biology. As Professor and Associate Dean for Research at the UCLA School of Dentistry and the Felix and Mildred Yip Endowed Chair in Dentistry, her research has significantly advanced understanding of the molecular and cellular mechanisms underlying periodontal disease, oral cancer, and host-microbiome interactions. Her laboratory’s pioneering investigations into the oral-gut-brain axis, bacteriocin therapeutics, and oral virome have shaped new paradigms in microbial pathogenesis, inflammation, and regenerative oral health. A prolific author with more than a hundred peer-reviewed publications in leading journals such as NPJ Biofilms and Microbiomes, Journal of Biological Chemistry, PLOS Pathogens, and Cell Death and Differentiation, Dr. Kapila’s work bridges fundamental discovery with translational innovation. She has served as principal investigator on multiple NIH-funded projects, including major initiatives exploring host–bacterial dynamics and microbiome modulation in oral and systemic disease contexts. Her editorial leadership extends across several international journals and major textbooks, including Periodontology 2000 and Newman and Carranza’s Clinical Periodontology, where she continues to shape scholarly discourse in the field. Dr. Kapila has received numerous prestigious honors recognizing her scientific excellence, mentorship, and contributions to dental research, including awards from the American Dental Association, the American Academy of Periodontology, and the American Association for Dental Research. A dedicated mentor, she has guided over a hundred trainees and junior faculty toward successful academic and research careers worldwide, championing inclusivity, rigorous scientific methodology, and leadership development. Through her interdisciplinary collaborations and global initiatives, Dr. Kapila continues to influence the future of oral health sciences, biomolecular therapeutics, and translational medicine, establishing herself as a leading voice in advancing oral-systemic health research on an international scale. She has 8347 citations from 146 documents with an h-index of 47.

Profiles: Scopus | ORCID

Publications

1. B. lactis HN019 modulates periapical inflammation and enhances cementum repair by increasing CEMP-1 expression in an animal model. (2025). Archives of Oral Biology.

2. The antimicrobial peptide nisin promotes host cell survival during SARS-CoV-2 infection. (2025). Virology Journal.

3. Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis. (2024). NPJ Biofilms and Microbiomes.

4. Biological biomarkers of oral cancer. (2025). [Journal name not specified].

5. Nisin, a probiotic bacteriocin, modulates the inflammatory and microbiome changes in female reproductive organs mediated by polymicrobial periodontal infection. (2024). Microorganisms.

Abdul-rahman Mumbu | Epidemiology | Best Researcher Award

Published on by Infectious

Mr. Abdul-rahman Mumbu | Epidemiology | Best Researcher Award

Lecturer | Muslim University of Morogoro | Tanzania

Dr. Abdul-Rahman Japhary Mumbu is a dedicated Lecturer in Mathematics at the Muslim University of Morogoro, Tanzania, recognized for his expertise in applied mathematics, mathematical modeling, and epidemiological systems. He holds a Bachelor of Islamic Education (Mathematics/Islamic Studies) from the Muslim University of Morogoro, a Master of Science in Mathematics from the University of Dodoma, and is currently pursuing a Ph.D. in Mathematics at the University of Dar es Salaam. His professional journey reflects progressive academic leadership, having served as an Assistant Lecturer, Examinations Officer, and active participant in numerous international workshops and conferences on infectious disease modeling, partial differential equations, and data-driven research integration. Dr. Mumbu’s research primarily focuses on mathematical modeling of infectious diseases, with notable contributions to tuberculosis, pneumonia, and rabies dynamics, employing deterministic and fractional-order approaches integrated with sensitivity and optimal control analyses. His scholarly works, published in reputable journals such as Nonlinear Science, Scientific African, and Research in Mathematics, highlight his commitment to advancing public health modeling and data-driven decision-making. With 40 citations, 4 publications, and an h-index of 2, Dr. Mumbu continues to make impactful contributions to mathematical epidemiology and interdisciplinary research collaboration.

Profiles: Scopus | Google Scholar

Featured Publications

1. Mumbu, A. J., & Hugo, A. K. (2020). Mathematical modelling on COVID-19 transmission impacts with preventive measures: A case study of Tanzania. Journal of Biological Dynamics, 14(1), 748–766.

2. Mumbu, A. (2024). Modeling dynamics and stability analysis of pneumonia disease infection with parameters uncertainties control. Mathematics Open, 3(2430001), 1–35.

3. Abdulrahman, M., James, D., Dickson, B., & Jufren, N. (2025). Mathematical modeling of culling and vaccination for dog rabies disease transmission with optimal control and sensitivity analysis approach. Clinical and Molecular Epidemiology, 2(2), 1–11.

4. Mumbu, A., Mlay, G., Mayige, M., & Shaban, N. (2025). Modeling the transmission dynamics of two-strain TB with drug-sensitive and drug-resistant in Tanzania: A fractional order approach. Scientific African, e02731.

5. Mumbu, A. R., Mlay, G., Alendal, G., Mayige, M., Senkoro, M., & Shaban, N. (2025). Fractional order derivative modelling dynamics of tuberculosis with treatment and nutrition in Tanzania. Research in Mathematics, 12(1), 2517440.

Lateef Busari | Epidemiology | Best Researcher Award

Published on by Infectious

Dr. Lateef Busari | Epidemiology | Best Researcher Award 

Researcher | Osun State University | Nigeria

Lateef Oluwatoyin Busari is a researcher at Osun State University, Nigeria, specializing in public health entomology, vector biology, medical parasitology, and neglected tropical diseases (NTDs). His research primarily focuses on vector-borne diseases, particularly onchocerciasis and malaria, with extensive work on black flies (Simulium damnosum complex) and mosquito vectors (Anopheles and Culex species) in Osun State and Southwestern Nigeria. He has authored and co-authored 14 scientific publications in reputable journals such as PLoS Neglected Tropical Diseases, PLoS ONE, Scientific Reports, Discover Animals, FUDMA Journal of Sciences, and Ife Journal of Science. His notable works include studies on black fly infectivity and community knowledge of onchocerciasis, insecticide susceptibility in mosquito populations, and larval habitat characteristics influencing mosquito breeding and distribution. Busari’s recent contributions also extend to geospatial modeling of mosquito distribution, bioethics awareness among biomedical researchers, and molecular detection of parasite infectivity in vectors, reflecting his multidisciplinary engagement in public health and ecological research. His collaborative network includes eminent scientists such as Prof. Monsuru Adeleke, Dr. Olabanji Surakat, Dr. Kamilu Ayo Fasasi, and others across Osun State University and Ladoke Akintola University of Technology. With a growing academic footprint, Busari has accumulated 31 citations, an h-index of 3, and an i10-index of 1, demonstrating his rising impact in vector research and tropical disease epidemiology. His scholarly contributions continue to enhance understanding and control strategies for vector-borne diseases in Nigeria.

1. Busari, L. O., Adeleke, M. A., Surakat, O. A., Akindele, A. A., Fasasi, K. A., & others. (2022). Black flies and Onchocerciasis: Knowledge, attitude and practices among inhabitants of Alabameta, Osun State, Southwestern, Nigeria.PLoS Neglected Tropical Diseases, 16(4), e0010320. Cited by: 15

2. Busari, L. O., Raheem, H. O., Iwalewa, Z. O., Fasasi, K. A., & Adeleke, M. A. (2023). Investigating insecticide susceptibility status of adult mosquitoes against some class of insecticides in Osogbo metropolis, Osun State, Nigeria. PLoS ONE, 18(5), e0285605. Cited by: 8

3. Busari, L. O., Ojurongbe, O., Adeleke, M. A., Surakat, O. A., & Akindele, A. A. (2021). Biting behaviour and infectivity of Simulium damnosum complex with Onchocerca parasite in Alabameta, Osun State, Southwestern, Nigeria. PLoS ONE, 16(6), e0252652. Cited by: 7

4. Adeleke, M. A., Babalola, A. S., Busari, L. O., Surakat, O. A., Rufai, A. M., Fasasi, K. A., & others. (2025). Modelling species distribution of Anopheles gambiae s.l. in Osun State using random forest modeling approach. Scientific Reports, 15(1), 16524. Cited by: 1

5. Busari, L. O., Surakat, O. A., Adeogun, A. O., Rufai, A. M., Fasasi, K. A., & Adeleke, M. A. (2025). Anopheles gambiae s.l. (Diptera: Culicidae) larval habitat and its public health implication in Osun State, Nigeria. Discover Animals, 2(1), 1–7.

Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

Published on by Infectious

Dr. Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

MD | Tehran University of Medical Sciences | Iran

Dr. Shayan Zamani is a dedicated Clinical Research Fellow at the Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, where he has established a strong foundation in dermatology, oncology, and hematopoietic stem cell transplantation. He earned his Doctor of Medicine (MD) with a focus on dermatologic research and clinical therapeutics, combining his medical expertise with evidence-based research in complex dermatological and oncologic disorders. Throughout his career, Dr. Zamani has contributed to multidisciplinary research collaborations exploring topics such as graft-versus-host disease (GVHD), drug-resistant fungal infections, cutaneous complications in oncology patients, and innovative nanoliposomal treatments for fungal and inflammatory skin diseases. His professional experience spans both clinical and laboratory environments, where he integrates translational methodologies to improve diagnostic precision and patient outcomes. His research interests center on dermatologic oncology, infectious skin diseases, immunodermatology, and regenerative therapies, supported by his skills in clinical trial design, biomarker analysis, molecular diagnostics, and data-driven evaluation of treatment efficacy. Dr. Zamani has authored several peer-reviewed publications in reputable journals such as JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Frontiers in Oncology, and Dermatologic Therapy, contributing valuable insights into skin disease pathophysiology and treatment optimization. His work has earned him recognition for academic excellence and commitment to advancing medical science. Dr. Zamani has actively participated in research collaborations and conferences, reflecting strong leadership and dedication to clinical innovation. With a growing publication record and a clear focus on improving therapeutic outcomes, he continues to strengthen his role in advancing dermatologic and oncologic research globally. His academic impact is demonstrated by 19 citations , 11 publications, and an h-index of 3.

Profiles : Google Scholar | Scopus | ORCID

Featured Publications

1. Tamimi, P., Fattahi, M., Ghaderi, A., Firooz, A., Shirvani, F., Alkhen, A., & Zamani, S. (2024). Terbinafin‐resistente Trichophyton indotineae mit F397L/L393S‐ oder F397L/L393F‐Mutation bei Patienten mit Tinea incognita unter Glukokortikosteroiden. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(7), 922–935.

2. Samadi, A., Ayatollahi, A., Kashani, M. N., Zamani, S., & Firooz, A. (2023). Efficacy and tolerability assessment of a polynucleotide‐based gel for improvement of pattern hair loss: A polynucleotide‐based gel for improvement of pattern hair loss. [Journal name not specified].

3. Mehdizadeh, M., Tehrani, H. A., Rezvani, H., Zamani, S., Salari, S., & Hajifathali, A. (2023). Maintenance therapy with Everolimus in patients with refractory or relapsing Hodgkin lymphoma after autologous stem cell transplantation. Blood Cell Therapy, 6(3), 87–93.

4. Zamani, S., Azhdari, H., & Mehdizadeh, M. (2023). Efficacy and safety profile of Everolimus as a maintenance therapy for primary refractory/relapsing Hodgkin lymphoma following autologous hematopoietic stem cell transplantation. HemaSphere, 7(S3), e9236902.

5. Zamani, S., Mehdizadeh, M., & Salem, A. (2023). Allogeneic stem cell transplantation outcomes in Hodgkin lymphoma: A prognostic study of 30 patients with relapsed and refractory Hodgkin lymphoma. HemaSphere, 7(S3), e621289b.

 

Albert Eisenbarth | Infectious Diseases Prevention | Best Researcher Award

Published on by Infectious

Dr. Albert Eisenbarth | Infectious Diseases Prevention | Best Researcher Award

Head of Medical Entomology Unit | Bundeswehr Hospital Hamburg | Germany

Albert Eisenbarth is an accomplished researcher at the Bundeswehr Hospital Hamburg, Germany, specializing in infectious diseases, tropical medicine, and vector biology. He holds a Ph.D. in Medical Biology from the University of Hamburg  where his doctoral work focused on the ecology and control of mosquito-borne pathogens. Over the years, Dr. Eisenbarth has gained extensive professional experience leading and collaborating on multidisciplinary research projects across Europe and Africa, particularly in the molecular detection and epidemiology of parasitic and vector-borne diseases. His research interests encompass mosquito ecology, disease transmission modeling, public health interventions, and the application of artificial intelligence in entomological studies. Dr. Eisenbarth possesses strong research skills in molecular biology, field entomology, data analytics, and bioinformatics, which he applies to enhance disease surveillance and vector control programs. His collaborative approach and scientific leadership have contributed to the success of international initiatives investigating malaria, leishmaniasis, and arbovirus transmission. A dedicated academic and mentor, he has co-authored numerous peer-reviewed papers published in reputed journals such as Scientific Data, Acta Tropica, and Travel Medicine and Infectious Disease. His contributions to research excellence have earned him recognition within the scientific community, including invitations to present at international symposia and participate in global health research networks. Dr. Eisenbarth’s continuing commitment to bridging field research with applied innovations reflects his passion for advancing global public health outcomes. His long-term vision involves fostering stronger international collaborations and mentoring early-career scientists in tropical disease research. Through his scholarly achievements and leadership, he continues to make a meaningful impact in biomedical research and public health policy.Dr. Albert Eisenbarth has an impressive academic record with 418 citations across 31 published documents and an h-index of 14, reflecting the strong impact and consistency of his research contributions in infectious diseases and vector biology.


Profiles : ORCID | Scopus

Featured Publications

1. Nolte, K., Agboli, E., Garcia, G. A., Badolo, A., Becker, N., Loc, D. H., Dworrak, T. V., Eguchi, J., Eisenbarth, A., de Freitas, R. M., et al. (2025). Comprehensive mosquito wing image repository for advancing research on geometric morphometric- and AI-based identification.

2. Lubbers, C., Amaral, L.-J., Colebunders, R., Brattig, N., Hadermann, A., & Eisenbarth, A. (2025, October). The last mile in onchocerciasis elimination: Diagnostic challenges.

3. Krüger, A., Balczun, C., Scheid, P. L., Hagen, R. M., & Eisenbarth, A. (2023). Molecular detection of Leishmania (Sauroleishmania) adleri (Trypanosomatida: Trypanosomatidae) in Sergentomyia sp. sand flies (Diptera: Psychodidae) in Mali and Niger.

4. Stoek, F., Barry, Y., Ba, A., Schulz, A., Rissmann, M., Wylezich, C., Sadeghi, B., Beyit, A. D., Eisenbarth, A., N’diaye, F. B., et al. (2022, April 15). Mosquito survey in Mauritania: Detection of Rift Valley fever virus and dengue virus and the determination of feeding patterns.

5. Ngwasiri, N. N., Brattig, N. W., Ndjonka, D., Liebau, E., Paguem, A., Leusder, D., Kingsley, M. T., Eisenbarth, A., Renz, A., & Daniel, A. M. (2021). Correction to: Galectins from Onchocerca ochengi and O. volvulus and their immune recognition by Wistar rats, Gudali zebu cattle and human hosts.

 

 

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Published on by Infectious

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Wenzhou Sixth People’s Hospital | China.

Author Profile

Scopus

🎓Education

Master’s Degree – Wenzhou Medical College

💼Professional Experience

Mr. Jiang has held several key leadership positions in the healthcare sector. He serves as the Deputy Secretary of the Party Committee at Wenzhou Central Hospital and previously led as the President of the Sixth People’s Hospital of Wenzhou. During the COVID-19 pandemic, he played a critical role as the Leader of the COVID-19 Treatment Team in Wenzhou, ensuring effective patient care and outbreak control. Additionally, he led the Wenzhou Medical Team in Shanghai, where he also served as the Temporary Party Branch Secretary, overseeing medical operations and emergency response efforts.

📚Academic Contributions

Mr. Jiang has made significant contributions to medical research, with 17+ SCI-indexed publications and over 30 articles in Chinese medical journals. He has also served as an editor of two medical books, further advancing knowledge in infectious disease management. His research efforts extend to national and provincial projects, where he has played a key role in developing innovative healthcare solutions and public health strategies.

🧑‍🔬Technical Skills 

Mr. Xiangao Jiang possesses advanced expertise in infectious disease diagnosis and treatment, specializing in managing hepatitis, chronic liver diseases, tuberculosis, and other critical infections. His proficiency extends to critical care management, where he has played a key role in handling complex and severe infectious disease cases. Additionally, his strong leadership in medical administration and public health response has been demonstrated through his roles in hospital management, pandemic control, and policy implementation, ensuring effective healthcare delivery and crisis management.

📚Teaching Experience

Tutor for postgraduate students at Wenzhou Medical University & Shanghai University

🏆Awards and Honors

Mr. Jiang’s outstanding contributions to medicine and healthcare have earned him the prestigious titles of Wenzhou Famous Doctor and Ou Yue Famous Doctor. His leadership and expertise have also been recognized through his selection as a Health Leading Talent under Zhejiang Province’s “Ten Thousand People Plan”, a distinction awarded to top professionals making significant impacts in their fields.

🔬Research Interests

Mr. Jiang’s research focuses on hepatitis and chronic liver diseases, with an emphasis on understanding disease progression and developing effective treatment strategies. He is also deeply engaged in infectious disease epidemiology, studying patterns and risk factors to enhance prevention and control measures. Additionally, his work in public health and outbreak management has contributed to improving emergency response strategies and healthcare policies, particularly in the face of emerging infectious threats.

📑Notable Publications 

‘Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China’
Authors: C. Qiu, Chaochao; X. Lin, Xiaoqing; Q. Zhang, Qiang; J. Shi, Jichan; X. Jiang, Xiangao
Year: 2025
Journal: BMC Infectious Diseases

‘Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus’
Authors: L. Wu, Lianpeng; N. Chen, Na; D. Xia, Dandan; X. Jiang, Xiangao
Year: 2025
Journal: Frontiers in Medicine

 ‘Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysisy’
Authors: X. Cai, Xiaoxiao; X. Xu, Xueqin; G. He, Guiqing; X. Jiang, Xiangao; L. Wu, Lianpeng
Year: 2024
Journal: BMC Infectious Diseases

‘Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant Mycobacterium tuberculosis isolates in Wenzhou, China‘

Authors: G. He, Guiqing; Q. Zheng, Qingyong; J. Wu, Jing; X. Jiang, Xiangao; X. Yu, Xia
Year: 2024
Journal: Microbiology Spectrum

Huali Xue | Disease Control | Best Researcher Award

Published on by Infectious

Huali Xue | Disease Control | Best Researcher Award

Prof Dr. Huali Xue , Gansu Agricultural University, China.

Dr. Huali Xue is a distinguished researcher in the field of disease control, renowned for her groundbreaking work in public health and epidemiology. With a focus on infectious diseases, her research has significantly contributed to the development of innovative strategies for disease prevention and management. Recognized for her excellence and dedication to improving global health, Dr. Xue has earned the Best Researcher Award for her impactful studies, which continue to shape policies and interventions aimed at reducing the spread of diseases. Her expertise and leadership in the field have made her a key figure in advancing disease control efforts worldwide.

Professional Profiles

Scopus Profile

Orcid Profile

📚Education

Dr. Huali Xue holds a Ph.D. in Crop Protection from Gansu Agricultural University, China (2015), where she focused on the accumulation of trichothecenes in potato tubers and their induced resistance mechanisms. She earned a Master’s in Organic Chemistry from Northwest Normal University, China (2004), with research on the synthesis and photochromism of polymeric materials. Dr. Xue completed her Bachelor’s in Chemistry Education at Shanxi Datong University, China (2001), providing a strong foundation in both chemistry and education.

💼Experience

Dr. Huali Xue is currently a Professor at the College of Science, Gansu Agricultural University (2018-Present), where she has also held positions as Associate Professor (2012-2018) and Assistant Professor (2007-2012). She began her academic career as a Teaching Assistant at the university (2004-2007). Additionally, Dr. Xue was a Visiting Scholar at McGill University, Canada (2016-2017), further expanding her research expertise in plant protection and disease control. Throughout her career, she has contributed to both teaching and research in crop protection and plant pathology.

 

🔬Research Interest

Dr. Xue’s research investigates the molecular mechanisms of plant resistance to pathogens, with a particular focus on the regulation of trichothecene biosynthesis, oxidative stress responses in plants, and the detoxification of mycotoxins. Her projects explore the role of reactive oxygen species (ROS), calcium signaling, and plant defense pathways in mitigating disease and mycotoxin accumulation.

 

👩‍🏫Technical Skills

Dr. Xue is proficient in molecular biology techniques, proteomics, and the study of plant-pathogen interactions, focusing on trichothecenes, reactive oxygen species (ROS), and plant defense mechanisms. Her work also includes the development of strategies to reduce mycotoxin contamination in crops.

🎤Academic Citations & Presentations

Dr. Xue has presented at several international conferences, including the 10th International Congress of Plant Pathology (ICPP) in 2013, the International Mycotoxin Conference 2014 (ISM2014), and the III International Symposium on Postharvest Pathology in 2015, where she shared her research on trichothecene production and mycotoxin reduction in crops.

📑Top Note Publications

Title: TrSnt2-mediated histone H3 deacetylation governs mitophagy, ROS accumulation, ergosterol synthesis, and pathogenicity in Trichothecium roseum

Authors: Xu, X., Zong, Y., Wang, B., …, Prusky, D., Bi, Y.
Publication Year: 2024
Citations: 0

Title: Effects of TrPLDs on the pathogenicity of Trichothecium roseum infected apple fruit

Authors: Liu, Q., Zhang, Q., Xue, H., …, Liu, Z., Dov, P.
Publication Year: 2024
Citations: 0

Title: Trichothecium roseum epigenetic reader Snt2 in phenotype and pathogenicity regulation

Authors: Xu, X., Wang, B., Gong, D., …, Bi, Y., Zong, Y.
Publication Year: 2024
Citations: 0

Title: ROS mediated by TrPLD3 of Trichothecium roseum participated in cell membrane integrity of apple fruit by influencing phosphatidic acid metabolism

Authors: Zhang, Q., Liu, Q., Xue, H., …, Liu, Z., Prusky, D.
Publication Year: 2024
Citations: 4

Title: Ozone Application Suppressed the Blue Mold Development and Maintained the Main Active Ingredients Content of Postharvest Fresh Codonopsis pilosula during Storage

Authors: Chen, J., Liu, Z., Liu, Q., …, Shang, S., Bi, Y.
Publication Year: 2024
Citations: 1